Dr. Adam Cohen

We will be holding our next regular monthly Philadelphia Multiple Myeloma Networking Group (PMMNG) meeting on Saturday, February 10, 2024 from 1:30-3:00 PM EST via Zoom.  Our meeting will feature an update on the American Society for Hematology (ASH) 2023 conference, which was held in San Diego, CA in December. (The link goes to search results listing the 852 abstracts for multiple myeloma.)

Dr. Shivani Kapur, Assistant Professor of Clinical Medicine, Penn Multiple Myeloma Program, will give us a summary of the key research results from ASH. There was very encouraging news about new drugs and combinations of drugs to treat multiple myeloma presented at this meeting, so join the meeting to hear all about it. 

Dr Kapur has a broad background in hematology oncology, and her presentations and publications reflect a wide range of topics relevant to the field, including the treatment of multiple myeloma and acute myeloid leukemia and their ancillary effects.

Note: In addition, because March is Myeloma Action Month, Marilyn Alexander will talk about how you can get involved to help spread the word about multiple myeloma. She will discuss the letter attached near the bottom of this page and will show a short video.

All PMMNG members will receive a meeting invitation via email.  If you are new to the group or our meetings, contact Barbara Falkowitz (b[email protected]) to receive the meeting link. 

We look forward to seeing you on Zoom!

NOTE: The presentation recording is available here. (The recording was accidentally started a little ways into the presentation, but there's lots of good material in what was recorded!)

Attachments:


blood labs

Our next monthly PMMNG meeting will be Saturday January 13, 2024 from 1:30-3:00 PM ET. This meeting with be conducted by Zoom.

This meeting will feature a presentation, ”All the questions you want to ask about labs…answered”, by Colleen Erb. It will cover multiple myeloma lab tests from basics to complex, including a bit on the newest tests being used to detect myeloma, minimal residual disease (MRD) tests. Please bring your questions!

As usual another important part of the meeting will be our small group breakout sessions. These breakout sessions give us a chance to catch up with each other in a small group, informal setting. In addition, these breakout sessions give folks a chance to bring up any questions they may have about their myeloma symptoms, treatment, etc.

Colleen Erb MSN, CRNP, ACNP-BC, AOCNP is a certified oncology nurse practitioner who is currently working at Jefferson Health - Asplundh Cancer Pavilion.  She has over 20 years experience in hematology/oncology and has also worked at Penn Medicine and Fox Chase Cancer Center in the Hematology/Oncology/Bone Marrow Transplant groups.  She has been involved with the Oncology Nursing Society at the local level for many years and has served as a writer for supportive care information in textbooks and journal articles. She was a part of the Putting Evidence Into Practice teams (now ONS Clinical Guidelines) for Prevention of Infection, Chemotherapy Induced Peripheral Neuropathy, chemotherapy-induced diarrhea, and anorexia. She has presented on supportive care topics and heme malignancies nationally for patients and providers. 

As always, patients and care partners are welcome to attend. 

All PMMNG members will receive a meeting invitation via email.  If you are new to the group, contact Barbara Falkowitz ([email protected]) to receive the meeting link. 

We look forward to seeing you on Zoom!

Note: Colleen's slides are below in the attachments section.

Attachments:


Tentative list of upcoming PMMNG meeting program topics and speakers:

2024

  • February 10: "Highlights from 2023 American Society for Hematology (ASH) Meeting" Dr. Shivani Kapur
  • March 9: "CAR-T and Bi-Specifcs Treatments" Dr. Alfred Garfall
  • April 13: "It's OK to Not Be OK" Molly Davis and Christina Bach

General Meeting Information

WHEN: Second Saturday of Every Month (except August)
TIME: 1:30 – 3:30 PM
WHERE: Via Zoom until further notice due to the coronavirus pandemic

In the future we may return to having some in-person or hybrid meetings. 

pmmng meeting